These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2443777)

  • 1. Inhibition of HIV replication in vitro by fusidic acid.
    Faber V; Dalgleish AG; Newell A; Malkovsky M
    Lancet; 1987 Oct; 2(8563):827-8. PubMed ID: 2443777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "On the shelf" AIDS drug in clinical trial.
    Barnes DM
    Science; 1987 Oct; 238(4825):276. PubMed ID: 3310231
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of activity of fusidic acid against human immunodeficiency virus in monocytes.
    Maehlen T; Degré M
    Antimicrob Agents Chemother; 1989 May; 33(5):680-3. PubMed ID: 2473711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suramin in the treatment of AIDS: mechanism of action.
    De Clercq E
    Antiviral Res; 1987 Jan; 7(1):1-10. PubMed ID: 2432836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bile salts and of fusidic acid on HIV-1 infection of cultured cells.
    Lloyd G; Atkinson T; Sutton PM
    Lancet; 1988 Jun; 1(8600):1418-21. PubMed ID: 2898581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusidic acid, HIV, and host cell toxicity.
    Richman DD; Mitsuya H; Broder S; Hostetler KY
    Lancet; 1988 May; 1(8593):1051-2. PubMed ID: 2896889
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS.
    Land S; Terloar G; McPhee D; Birch C; Doherty R; Cooper D; Gust I
    J Infect Dis; 1990 Feb; 161(2):326-9. PubMed ID: 2299212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro efficacy of fusidic acid in HIV infection.
    Famularo G; De Simone C; Tzantzoglou S; Trinchieri V; Moretti S; Tonietti G
    Ann N Y Acad Sci; 1993 Jun; 685():341-3. PubMed ID: 7689807
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlations between the in vitro and in vivo activity of anti-HIV agents: implications for future drug development.
    Yarchoan R; Broder S
    J Enzyme Inhib; 1992; 6(1):99-111. PubMed ID: 1285306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV activity of dideoxynucleosides, foscarnet and fusidic acid is potentiated by human leukocyte interferon in blood-derived macrophages.
    Degré M; Beck S
    Chemotherapy; 1994; 40(3):201-8. PubMed ID: 7515781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple whammy. Will an AIDS therapy live up to its advance billing?
    Rennie J
    Sci Am; 1993 May; 268(5):18, 22. PubMed ID: 7683141
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reverse transcriptase inhibitors and the therapy of HIV infection].
    Kraevskiĭ AA; Galegov GA
    Vestn Ross Akad Med Nauk; 1992; (11-12):3-6. PubMed ID: 1284219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
    Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fusidic acid on migration and chemiluminescence of polymorphonuclear leukocytes.
    Naess A; Flø RW; Solberg CO
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):42-4. PubMed ID: 2303066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusidic acid non-antibacterial activity.
    Christiansen K
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S73-8. PubMed ID: 10528789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between rifabutin and human immunodeficiency virus type 1: inhibition of replication, cytopathic effect, and reverse transcriptase in vitro.
    Anand R; Moore JL; Curran JW; Srinivasan A
    Antimicrob Agents Chemother; 1988 May; 32(5):684-8. PubMed ID: 2456033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular bases in the search for drugs for treating AIDS. Achievements and possible prospects].
    Kraevskiĭ AA
    Mol Biol (Mosk); 1999; 33(3):343-52. PubMed ID: 10519109
    [No Abstract]   [Full Text] [Related]  

  • 18. Fusidic acid: new opportunities with an old antibiotic.
    Anderson JD
    Can Med Assoc J; 1980 Apr; 122(7):765-9. PubMed ID: 6988070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotides as inhibitors of human immunodeficiency virus.
    Field AK
    Curr Opin Mol Ther; 1999 Jun; 1(3):323-31. PubMed ID: 11713797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.